FOMAT Medical Research
FOMAT Medical Research is California's largest research site network, dedicated to advancing clinical research and improving patient outcomes. With over 10 years of experience, it operates multiple sites across California, focusing on diversifying clinical trials and supporting organizations throughout their research journey. The organization collaborates with industry sponsors and CROs to accelerate the development of therapies across various therapeutic areas, emphasizing healthcare innovation through diversity.
Industries
Nr. of Employees
medium (51-250)
FOMAT Medical Research
Products
Active clinical studies — Asthma
Ongoing interventional clinical studies evaluating therapies for asthma, including assessments such as spirometry and blood tests; enrollment information for patients and healthy volunteers available.
Active clinical studies — Colorectal cancer
Ongoing clinical research focused on colorectal cancer prevention, diagnosis, and treatment modalities with community-based trial access.
Active clinical studies — Endocrinology & Metabolic
Ongoing trials addressing endocrine and metabolic disorders, including metabolic-associated steatohepatitis (MASH), obesity, and other metabolic conditions; emphasis on biomarker profiling and personalized approaches.
Active clinical studies — Asthma
Ongoing interventional clinical studies evaluating therapies for asthma, including assessments such as spirometry and blood tests; enrollment information for patients and healthy volunteers available.
Active clinical studies — Colorectal cancer
Ongoing clinical research focused on colorectal cancer prevention, diagnosis, and treatment modalities with community-based trial access.
Active clinical studies — Endocrinology & Metabolic
Ongoing trials addressing endocrine and metabolic disorders, including metabolic-associated steatohepatitis (MASH), obesity, and other metabolic conditions; emphasis on biomarker profiling and personalized approaches.
Services
Phase I clinical trial services
On-site and hybrid support for early-stage safety and dose-finding studies.
Phase II–IV clinical trial services
Support for mid- to late-stage efficacy and post-approval studies including recruitment, site management, and study coordination.
Site network and investigator partnership services
Qualification, onboarding and management of research sites and principal investigators to expand geographic and specialty coverage.
Regulatory and quality affairs support
Assistance with ethics committee/IRB interactions, regulatory submissions, and quality management across multi-site studies.
Digital and decentralized trial services
Implementation of electronic consent, CTMS integration, virtual visits and digital recruitment to support decentralized trial models.
Phase I clinical trial services
On-site and hybrid support for early-stage safety and dose-finding studies.
Phase II–IV clinical trial services
Support for mid- to late-stage efficacy and post-approval studies including recruitment, site management, and study coordination.
Site network and investigator partnership services
Qualification, onboarding and management of research sites and principal investigators to expand geographic and specialty coverage.
Regulatory and quality affairs support
Assistance with ethics committee/IRB interactions, regulatory submissions, and quality management across multi-site studies.
Digital and decentralized trial services
Implementation of electronic consent, CTMS integration, virtual visits and digital recruitment to support decentralized trial models.
Expertise Areas
- Clinical trial management
- Patient recruitment and retention
- Diversity and inclusion in clinical research
- Oncology clinical trials
Key Technologies
- Electronic informed consent (eConsent)
- Clinical Trial Management Systems (CTMS)
- Cloud-based clinical data systems
- AI-driven analytics for trial data